Scores of coronavirus vaccines are in competition — how will scientists choose the best? - ERP Spain.com - España y América Latina

Seven months after the world first learned about the new coronavirus causing fatal pneumonia in Wuhan, China, there are more than 90 vaccines for the virus at various stages of development, with more announced each week.

Now scientists, researchers, medical doctors, investors, etc. are trying to figure out which ones actually work and which ones are the best.  In this webinar, we show you how to run a quick effectiveness analysis. Using our virtual analytics hub, we access clinical trial data from three different drugs at the click of a mouse, enrich it with patients’ demographics and comorbidity data, before visualizing the results within your BI tool of choice.

Speakers:

Steve Egan

Senior Director Solutions Engineering

Nikhil Kumar

Senior Solutions Engineer